| C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: a bi-center study JM Riedl, DA Barth, WM Brueckl, G Zeitler, V Foris, S Mollnar, M Stotz, ... Cancers 12 (8), 2319, 2020 | 64 | 2020 |
| Long-noncoding RNA (lncRNA) in the regulation of hypoxia-inducible factor (HIF) in cancer DA Barth, F Prinz, J Teppan, K Jonas, C Klec, M Pichler Non-coding RNA 6 (3), 27, 2020 | 42 | 2020 |
| Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis JM Riedl, F Posch, L Horvath, A Gantschnigg, F Renneberg, ... European Journal of Cancer 151, 3-13, 2021 | 40 | 2021 |
| Non-coding RNAs and SARS-related coronaviruses H Henzinger, DA Barth, C Klec, M Pichler Viruses 12 (12), 1374, 2020 | 39 | 2020 |
| Current concepts of non-coding RNAs in the pathogenesis of non-clear cell renal cell carcinoma DA Barth, O Slaby, C Klec, J Juracek, R Drula, GA Calin, M Pichler Cancers 11 (10), 1580, 2019 | 38 | 2019 |
| Involvement of long non-coding RNAs (lncRNAs) in tumor angiogenesis J Teppan, DA Barth, F Prinz, K Jonas, M Pichler, C Klec Non-coding RNA 6 (4), 42, 2020 | 35 | 2020 |
| lncRNA and mechanisms of drug resistance in cancers of the genitourinary system DA Barth, J Juracek, O Slaby, M Pichler, GA Calin Cancers 12 (8), 2148, 2020 | 34 | 2020 |
| Circulating non-coding RNAs in renal cell carcinoma—pathogenesis and potential implications as clinical biomarkers DA Barth, R Drula, L Ott, L Fabris, O Slaby, GA Calin, M Pichler Frontiers in Cell and Developmental Biology 8, 828, 2020 | 26 | 2020 |
| Involvement of long non-coding RNAs in glucose metabolism in cancer A Balihodzic, DA Barth, F Prinz, M Pichler Cancers 13 (5), 977, 2021 | 23 | 2021 |
| Emerging role of non-coding RNAs in regulation of T-lymphocyte function M Taheri, DA Barth, J Kargl, O Rezaei, S Ghafouri-Fard, M Pichler Frontiers in Immunology 12, 756042, 2021 | 22 | 2021 |
| Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective … DA Barth, S Stanzer, J Spiegelberg, T Bauernhofer, G Absenger, F Posch, ... Cancer Medicine 11 (16), 3074-3083, 2022 | 21 | 2022 |
| External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients DA Barth, C Brenner, JM Riedl, F Prinz, EV Klocker, K Schlick, P Kornprat, ... Cancer Medicine 9 (15), 5473-5479, 2020 | 19 | 2020 |
| The AST/ALT ratio is an independent prognostic marker for disease-free survival in stage II and III colorectal carcinoma L Scheipner, MA Smolle, D Barth, F Posch, M Stotz, M Pichler, H Stoeger, ... Anticancer Research 41 (1), 429-436, 2021 | 18 | 2021 |
| Long non-coding RNA PANTR1 is associated with poor prognosis and influences angiogenesis and apoptosis in clear-cell renal cell cancer M Seles, GC Hutterer, J Foßelteder, M Svoboda, M Resel, DA Barth, ... Cancers 12 (5), 1200, 2020 | 15 | 2020 |
| MicroRNAs as appropriate discriminators in non-specific alpha-fetoprotein (AFP) elevation in testicular germ cell tumor patients AL Lembeck, P Puchas, G Hutterer, DA Barth, A Terbuch, T Bauernhofer, ... Non-coding RNA 6 (1), 2, 2020 | 13 | 2020 |
| Patterns of thromboembolism in patients with advanced pancreatic cancer undergoing first-line chemotherapy with FOLFIRINOX or gemcitabine/nab-paclitaxel JM Riedl, E Schwarzenbacher, F Moik, L Horvath, A Gantschnigg, ... Thrombosis and Haemostasis 122 (04), 633-645, 2022 | 12 | 2022 |
| Decreased activity of circulating butyrylcholinesterase in blood is an independent prognostic marker in pancreatic cancer patients EV Klocker, DA Barth, JM Riedl, F Prinz, J Szkandera, K Schlick, ... Cancers 12 (5), 1154, 2020 | 12 | 2020 |
| Patterns of peripheral blood b-cell subtypes are associated with treatment response in patients treated with immune checkpoint inhibitors: A prospective longitudinal pan-cancer … DA Barth, S Stanzer, JA Spiegelberg, T Bauernhofer, G Absenger, ... Frontiers in immunology 13, 840207, 2022 | 11 | 2022 |
| The lipase/amylase ratio (LAR) in peripheral blood might represent a novel prognostic marker in patients with surgically resectable pancreatic cancer M Stotz, DA Barth, JM Riedl, E Asamer, EV Klocker, P Kornprat, ... Cancers 12 (7), 1798, 2020 | 11 | 2020 |
| MiR-200c-3p modulates cisplatin resistance in biliary tract cancer by ZEB1-independent mechanisms F Posch, F Prinz, A Balihodzic, C Mayr, T Kiesslich, C Klec, K Jonas, ... Cancers 13 (16), 3996, 2021 | 8 | 2021 |
Martin PichlerMedical University of Graz在 medunigraz.at 的电子邮件经过验证
